Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1

dc.contributor.authorSeth D. Ludwig
dc.contributor.authorBunyarit Meksiriporn
dc.contributor.authorJiacheng Tan
dc.contributor.authorRakeeb Kureshi
dc.contributor.authorAkhilesh Mishra
dc.contributor.authorKyle J. Kaeo
dc.contributor.authorAngela Y. Zhu
dc.contributor.authorGeorgia Stavrakis
dc.contributor.authorStephen J. Lee
dc.contributor.authorDavid J. Schodt
dc.contributor.authorMichael J. Wester
dc.contributor.authorDhiraj Kumar
dc.contributor.authorKeith A. Lidke
dc.contributor.authorAndrea L. Cox
dc.contributor.authorHelen Dooley
dc.contributor.authorSridhar Nimmagadda
dc.contributor.authorJamie B. Spangler
dc.date.accessioned2026-05-08T19:20:53Z
dc.date.issued2024-3-27
dc.identifier.doi10.1016/j.chembiol.2024.02.014
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/17754
dc.publisherCell chemical biology
dc.subjectCAR-T cell therapy research
dc.subjectMonoclonal and Polyclonal Antibodies Research
dc.subjectCancer Immunotherapy and Biomarkers
dc.titleMultiparatopic antibodies induce targeted downregulation of programmed death-ligand 1
dc.typeArticle

Files

Collections